{
    "organizations": [],
    "uuid": "9f764947f711fd12d753aaa26bebec25a289f505",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-anthera-pharma-qtrly-net-loss-per/brief-anthera-pharma-qtrly-net-loss-per-share-applicable-to-common-stockholders-0-73-idUSASB0C8UW",
    "ord_in_thread": 0,
    "title": "BRIEF-Anthera Pharma Qtrly Net Loss Per Share Applicable To Common Stockholders $0.73",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 5 (Reuters) - Anthera Pharmaceuticals Inc:\n* ANTHERA PHARMACEUTICALS PROVIDES BUSINESS UPDATE AND REPORTS 2017 FOURTH QUARTER AND FISCAL YEAR FINANCIAL RESULTS\n* QTRLY NET LOSS PER SHARE APPLICABLE TO COMMON STOCKHOLDERS $0.73\n* Q4 EARNINGS PER SHARE VIEW $-0.66 â€” THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-06T05:21:00.000+02:00",
    "crawled": "2018-03-06T22:17:58.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "anthera",
        "pharmaceutical",
        "inc",
        "anthera",
        "pharmaceutical",
        "provides",
        "business",
        "update",
        "report",
        "fourth",
        "quarter",
        "fiscal",
        "year",
        "financial",
        "result",
        "qtrly",
        "net",
        "loss",
        "per",
        "share",
        "applicable",
        "common",
        "stockholder",
        "q4",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}